Alcohol occupies an unusual position in federal regulation: it is legally recognized as both a drug and a food, depending on how it’s being used. Ethyl alcohol appears in the U.S. Pharmacopeia, one of the official drug reference books under the Federal Food, Drug, and Cosmetic Act. That means when alcohol is intended for drug use, it must meet the standards laid out in that compendium. But the beer, wine, or cocktail you order at a bar is regulated primarily as a beverage, not as a pharmaceutical product.
This dual identity isn’t a loophole or an oversight. It reflects how federal law splits regulatory authority based on a product’s intended use, not just its chemical properties.
How Federal Law Splits the Difference
Two agencies share oversight of alcohol in the United States, and the line between them comes down to what the product is and how it’s sold. The Alcohol and Tobacco Tax and Trade Bureau (TTB) regulates distilled spirits, malt beverages, and wine with 7% or more alcohol content under the Federal Alcohol Administration Act. These products follow TTB’s labeling, advertising, and production rules rather than FDA’s.
Everything that falls outside TTB’s jurisdiction lands under FDA authority. The Federal Food, Drug, and Cosmetic Act defines food broadly as “articles used for food and drink,” so alcoholic beverages regulated by FDA are legally classified as food. This includes wines with less than 7% alcohol and certain specialty beers made without hops or with grain substitutes like sorghum, rice, or wheat. These products must follow FDA’s ingredient labeling, nutrition labeling, and allergen disclosure rules.
The practical result: most alcoholic beverages you encounter are exempt from FDA’s Nutrition Facts requirements. TTB has proposed requiring an “Alcohol Facts” panel on labels for products under its authority, with a compliance timeline of five years after a final rule is published. Until that takes effect, the nutrition information gap on most alcohol labels persists.
When the FDA Does Treat Alcohol as a Drug
Alcohol shows up in hundreds of FDA-approved medications. It serves as a solvent, a preservative, and sometimes an active ingredient. The FDA’s own guidance notes that alcohol “may be considered either active or inactive depending on the product formulation.” In a cough syrup, for instance, alcohol might function as an inactive ingredient that helps dissolve other compounds. In a different product, its sedative properties could be part of the intended therapeutic effect.
When alcohol is used this way, it falls squarely under FDA drug regulations. Manufacturers must meet pharmaceutical-grade purity standards, disclose alcohol content on labels, and follow the same approval processes as any other drug ingredient.
Why Alcohol Is Pharmacologically a Drug
Regardless of how regulators categorize it, alcohol acts on the brain in ways that are indistinguishable from other psychoactive drugs. It works by disrupting the balance between two types of chemical signaling in your nervous system.
First, alcohol amplifies your brain’s main braking system. It enhances the effect of an inhibitory chemical called GABA, which normally produces feelings of calm and sedation. At the same time, alcohol suppresses your brain’s primary accelerator, glutamate, which drives alertness and excitation. The combination of stronger brakes and a weaker accelerator is what produces the familiar effects of intoxication: slowed reflexes, reduced anxiety, impaired judgment, and eventually sedation.
This mechanism is essentially the same way that prescription sedatives and anti-anxiety medications work. The difference is packaging and context, not pharmacology.
How Public Health Agencies Classify Alcohol
Major health organizations treat alcohol as a substance of concern alongside tobacco and illicit drugs. The CDC groups alcohol with tobacco products, illicit drugs, and inhalants under its definition of “substance use,” tracking patterns of consumption through national surveys. The National Survey on Drug Use and Health collects data on alcohol use in the same framework as illicit drug use, measuring lifetime, past-year, and past-month consumption.
The FDA has approved three medications specifically for treating alcohol use disorder, reflecting its recognition that alcohol produces dependence comparable to other drugs. Disulfiram was the only option for over 40 years. Naltrexone followed in 1994 as an oral medication and in 2006 as a long-acting injection. Acamprosate was approved in 2004. The existence of these treatments underscores that the medical establishment views alcohol dependence as a pharmacological problem requiring pharmacological solutions.
Why the Regulatory Gap Exists
The reason alcohol isn’t regulated like other psychoactive substances comes down to history and economics, not science. Alcohol predates the modern regulatory framework by centuries. When Congress created the Federal Food, Drug, and Cosmetic Act in 1938 and established the system that would become TTB, alcoholic beverages were already deeply embedded in American commerce and culture. Rather than treating alcohol as a drug that happens to be consumed recreationally, lawmakers created a parallel regulatory track for it.
This means alcohol doesn’t appear on any schedule of the Controlled Substances Act, despite having a well-documented capacity for dependence, withdrawal, and organ damage. It isn’t subject to the same prescribing restrictions, purity testing, or risk disclosures that apply to other substances with similar pharmacological profiles. The chemical is the same whether it’s in a bottle of bourbon or a bottle of cough medicine. The rules that apply to it depend entirely on which bottle it’s in.